Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
With COO buy, plus previous RNS of holder over 4%, something brewing, maybe have to wait maybe 2 or 3 months but I think something going to happen.
Part 2 of Dr D Orrell article on Virtual Tumour Clinical now out on PYC b log.
https://www.physiomics.co.uk/the-virtual-tumour-part-ii/
Trial started Jan 2018, study finish date Marc 2022.
https://clinicaltrials.gov/ct2/show/NCT03486730
2 absracts presented by PYC last week.
https://www.page-meeting.org/default.asp?abstract=8954
https://www.page-meeting.org/default.asp?abstract=9005
riddler:-Taken from SAR RNS 09/01/2017 (The part I quoted about Sierra Oncology dishing out payment in 2020 I read a few months ago, not sure where).
Milestone Payment from Chk1 Licence Agreement
Sareum Holdings plc (AIM:SAR), the specialist cancer drug discovery and development company, is pleased to announce the attainment of a US$2.0 million success milestone payment as part of the Chk1 licence agreement between its co-investment partner, the CRT Pioneer Fund, and Sierra Oncology, Inc. (NASDAQ: SRRA), formerly, until today, ProNAi Therapeutics, Inc.
Under the terms of the agreement, first announced on 27 September 2016, the fee has become payable as a result of the successful transfer of the two ongoing Phase 1 clinical trials to Sierra Oncology. Further payments in the aggregate amount of up to US$319.5 million may additionally become payable upon achievement of certain development, regulatory and commercial milestones. Sierra Oncology will also pay high single to low double digit royalties on the net sales of any product successfully developed.
Under Sareum's agreements with Cancer Research Technology and the CRT Pioneer Fund, Sareum is entitled to 27.5% of all payments arising from the Chk1 licence agreeement. Therefore, Sareum will receive $550,000 as its financial share of this milestone event.
Riddler, Pyc received payment from Sar in Dec 2016, this worked out to about 2.5% - 3% of what payment Sareum received. I still believe Pyc will receive more payments, when SRA737 has been proven by Sierra Oncology, then Sareum will receive large payment, if I recall correclty will be first half of 2020.
Tweet about physiomics hosting a cancer cluster lunch last week at OSP.
https://www.google.co.uk/url?sa=t&source=web&rct=j&url=https://twitter.com/physiomics%3Flang%3Den&ved=2ahUKEwjD8J6qpfPiAhWC26QKHZNXAmsQjjgwAHoECAkQAw&usg=AOvVaw2gdiLq4CWBOPaWmywRj7Te
Tweet about physiomics hosting a cancer cluster lunch last week at OSP.
https://www.google.co.uk/url?sa=t&source=web&rct=j&url=https://twitter.com/physiomics%3Flang%3Den&ved=2ahUKEwjD8J6qpfPiAhWC26QKHZNXAmsQjjgwAHoECAkQAw&usg=AOvVaw2gdiLq4CWBOPaWmywRj7Te
Thanks for reply Robertb
Shore Capital reiterates Matd :- House Stock??
First blog is an insight into virtual tumour pt 1 by Dr David Orell.
https://www.physiomics.co.uk/the-virtual-tumour-part-i
Only 10 SME's at yesterday's event.
https://www.cancerbrc.org/news-events/events/sme-digital-dragons’-den
Good news for Physiomics.
https://www.biopharmadive.com/press-release/20190426-
medicines-discovery-catapults-virtual-rd-discovery-service
Medicines Discovery Catapult’s Virtual R&D Discovery Services platform announce twenty-two partnerships
Sorry try this lin
https://youtu.be/vwg5tW00E6A
Modelling the effect of Radiotherapy on tumour growth inhibition: the head and neck tumour case head and neck tumour case
https://www.physiomics.co.uk/wp-content/uploads/2019/04/PYCAACR2019_Radiation_680_final.pdf
A Precision Dosing Application For Advanced Prostate Cancer
Chemotherapy
https://www.physiomics.co.uk/wp-content/uploads/2019/04/Abstract677-1.pdf